Institutional Ownership Vaxcyte, Inc. (PCVX)
This table provides information about the institutional ownership of Vaxcyte, Inc. (PCVX). We have compiled data on the 353 institutions that hold shares in the stock, with a total of 122 Million shares, which have been reported (via 13F filing form) to have a value of $10.6 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
1,148,184
shares
|
$99 Million
0.05% of portfolio
|
Q3 2024
Added 782.8%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
1,103,945
shares
|
$95.2 Million
1.14% of portfolio
|
Q3 2024
Added 56.17%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Nov 14, 2024 Q3 2024 |
1,039,288
shares
|
$89.6 Million
9.73% of portfolio
|
Q3 2024
Added 37.98%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
1,036,417
shares
|
$89.3 Million
0.02% of portfolio
|
Q3 2024
Added 10.29%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,000,000
shares
|
$86.2 Million
8.0% of portfolio
|
Q3 2024
Reduced 9.09%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
995,779
shares
|
$85.8 Million
0.7% of portfolio
|
Q3 2024
New holding
|
|
|
Lee Ainslie
Maverick Capital LTD | Dallas, Tx
|
Nov 14, 2024 Q3 2024 |
976,249
shares
|
$84.2 Million
2.31% of portfolio
|
Q3 2024
Added 41.92%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
949,251
shares
|
$81.8 Million
0.02% of portfolio
|
Q3 2024
Added 28.84%
|
|
|
Commodore Capital LP
New York, NY |
Nov 14, 2024 Q3 2024 |
920,000
shares
|
$79.3 Million
8.92% of portfolio
|
Q3 2024
Reduced 29.5%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 15, 2024 Q3 2024 |
879,405
shares
|
$75.8 Million
5.4% of portfolio
|
Q3 2024
Reduced 15.39%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 12, 2024 Q3 2024 |
780,905
shares
|
$67.3 Million
0.1% of portfolio
|
Q3 2024
Added 46.54%
|
|
|
Novo Holdings
Hellerup, G7 |
Oct 24, 2024 Q3 2024 |
750,000
shares
|
$64.7 Million
5.99% of portfolio
|
Q3 2024
Reduced 21.05%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
694,869
shares
|
$59.9 Million
0.01% of portfolio
|
Q3 2024
Added 69.61%
|
|
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
Nov 13, 2024 Q3 2024 |
639,539
shares
|
$55.1 Million
57.56% of portfolio
|
Q3 2024
Reduced 19.36%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
627,732
shares
|
$54.1 Million
2.58% of portfolio
|
Q3 2024
Added 0.08%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
569,890
shares
|
$49.1 Million
0.01% of portfolio
|
Q3 2024
Added 20.92%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Nov 14, 2024 Q3 2024 |
546,835
shares
|
$47.1 Million
0.11% of portfolio
|
Q3 2024
Added 18.19%
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2024 Q3 2024 |
529,005
shares
|
$45.6 Million
0.04% of portfolio
|
Q3 2024
Added 0.27%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 13, 2024 Q3 2024 |
501,050
shares
|
$43.2 Million
0.13% of portfolio
|
Q3 2024
Added 17.72%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
463,937
shares
|
$40 Million
0.02% of portfolio
|
Q3 2024
Added 42.68%
|
|
|
Brown Advisory Inc
|
Nov 13, 2024 Q3 2024 |
444,039
shares
|
$38.3 Million
0.07% of portfolio
|
Q3 2024
Added 20.92%
|
|
|
Amundi
Paris, I0 |
Nov 13, 2024 Q3 2024 |
434,792
shares
|
$37.5 Million
0.02% of portfolio
|
Q3 2024
Reduced 1.7%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
423,498
shares
|
$36.5 Million
0.05% of portfolio
|
Q3 2024
Added 83.96%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
408,274
shares
|
$35.2 Million
0.01% of portfolio
|
Q3 2024
Added 38.04%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
387,000
shares
|
$33.4 Million
1.04% of portfolio
|
Q3 2024
Reduced 51.38%
|